Published: 8 December 2016
Publications
Recent Approvals of Medicines containing a New Active Ingredient
Prescriber Update 37(4): 58
December 2016
For period 16 July to 15 October 2016
TradeName (Active ingredient) | Dose form and strength | Therapeutic area |
---|---|---|
Cyramza (ramucirumab) | Concentrate for infusion 100 mg/10 mL and 50 mg/50 mL |
Advanced or metastatic gastric or gastro- oesophageal junction adenocarcinoma |
Sirturo (bedaquiline) | Tablet 100 mg | Multi-drug resistant tuberculosis |
The data sheets for currently marketed prescription medicines are published
on the Medsafe website (www.medsafe.govt.nz/profs/Datasheet/dsform.asp).